Vincent Medical, a leading name in the medical device industry, is headquartered in Hong Kong and operates extensively across Asia and beyond. Founded in 2001, the company has established itself as a pioneer in the development of innovative respiratory and anaesthesia solutions, catering to the needs of healthcare professionals worldwide. Specialising in high-quality medical equipment, Vincent Medical offers a range of products, including advanced nebulisers and oxygen therapy devices, known for their reliability and user-friendly design. The company’s commitment to research and development has positioned it as a trusted partner in the healthcare sector, with notable achievements in enhancing patient care and safety. With a strong market presence and a reputation for excellence, Vincent Medical continues to lead the way in medical technology, striving to improve health outcomes globally.
How does Vincent Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vincent Medical's score of 35 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Vincent Medical reported total carbon emissions of approximately 5,651,160 kg CO2e, a decrease from about 7,210,800 kg CO2e in 2023. The emissions breakdown for 2024 includes Scope 1 emissions of about 62,850 kg CO2e, Scope 2 emissions of approximately 5,353,760 kg CO2e, and Scope 3 emissions of about 92,150 kg CO2e. This reflects a significant reduction in total emissions, indicating a positive trend in their climate commitments. Vincent Medical's emissions data is cascaded from its parent company, Vincent Medical Holdings Limited, which provides a comprehensive overview of their carbon footprint. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) or other formal climate pledges, but it continues to monitor and report its emissions across all relevant scopes. Historically, Vincent Medical's emissions have shown fluctuations, with total emissions peaking at about 12,315,000 kg CO2e in 2022. The company has made strides in reducing its Scope 2 emissions, which accounted for the majority of its carbon footprint in previous years. The commitment to transparency in emissions reporting aligns with industry standards, showcasing their dedication to addressing climate change. Overall, Vincent Medical's ongoing efforts to reduce carbon emissions demonstrate a commitment to sustainability, although specific reduction initiatives or targets have not been disclosed.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 14,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 | 00,000 | 
| Scope 2 | 10,855,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 
| Scope 3 | 231,000 | 000,000 | 0,000 | 0,000 | 00,000 | 00,000 | 00,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vincent Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
